Blueprint Medicines Corporation (BPMC)
USD 80.71
(-7.35%)
USD 80.71
(-7.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 918.64 Million USD | 9.99% |
| 2022 | 835.22 Million USD | 196.72% |
| 2021 | 281.49 Million USD | 13.36% |
| 2020 | 248.3 Million USD | 2.04% |
| 2019 | 243.33 Million USD | 100.91% |
| 2018 | 121.11 Million USD | 31.98% |
| 2017 | 91.76 Million USD | 31.63% |
| 2016 | 69.71 Million USD | 99.65% |
| 2015 | 34.91 Million USD | 140.89% |
| 2014 | 14.49 Million USD | 157.43% |
| 2013 | 5.63 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 727.78 Million USD | -20.78% |
| 2024 Q3 | 886.5 Million USD | 0.36% |
| 2024 Q2 | 883.31 Million USD | 21.37% |
| 2023 Q4 | 918.64 Million USD | 1.77% |
| 2023 FY | 918.64 Million USD | 9.99% |
| 2023 Q1 | 806.07 Million USD | -3.49% |
| 2023 Q2 | 795.31 Million USD | -1.33% |
| 2023 Q3 | 902.68 Million USD | 13.5% |
| 2022 Q2 | 444.69 Million USD | 69.96% |
| 2022 Q1 | 261.64 Million USD | -7.05% |
| 2022 Q4 | 835.22 Million USD | 2.1% |
| 2022 Q3 | 818.08 Million USD | 83.97% |
| 2022 FY | 835.22 Million USD | 196.72% |
| 2021 Q1 | 225.36 Million USD | -9.24% |
| 2021 FY | 281.49 Million USD | 13.36% |
| 2021 Q4 | 281.49 Million USD | 22.26% |
| 2021 Q3 | 230.23 Million USD | -4.07% |
| 2021 Q2 | 239.99 Million USD | 6.49% |
| 2020 Q1 | 230.69 Million USD | -5.2% |
| 2020 FY | 248.3 Million USD | 2.04% |
| 2020 Q3 | 238.17 Million USD | 0.88% |
| 2020 Q2 | 236.09 Million USD | 2.34% |
| 2020 Q4 | 248.3 Million USD | 4.25% |
| 2019 Q3 | 221.58 Million USD | 3.37% |
| 2019 FY | 243.33 Million USD | 100.91% |
| 2019 Q4 | 243.33 Million USD | 9.82% |
| 2019 Q2 | 214.35 Million USD | 6.93% |
| 2019 Q1 | 200.45 Million USD | 65.5% |
| 2018 Q4 | 121.11 Million USD | 3.68% |
| 2018 FY | 121.11 Million USD | 31.98% |
| 2018 Q1 | 93.59 Million USD | 1.99% |
| 2018 Q2 | 112.18 Million USD | 19.86% |
| 2018 Q3 | 116.81 Million USD | 4.13% |
| 2017 Q4 | 91.76 Million USD | 16.34% |
| 2017 Q3 | 78.87 Million USD | 11.67% |
| 2017 FY | 91.76 Million USD | 31.63% |
| 2017 Q1 | 64.42 Million USD | -7.59% |
| 2017 Q2 | 70.63 Million USD | 9.63% |
| 2016 FY | 69.71 Million USD | 99.65% |
| 2016 Q3 | 70.13 Million USD | -5.16% |
| 2016 Q4 | 69.71 Million USD | -0.6% |
| 2016 Q2 | 73.95 Million USD | -3.13% |
| 2016 Q1 | 76.35 Million USD | 118.65% |
| 2015 Q4 | 34.91 Million USD | -6.0% |
| 2015 FY | 34.91 Million USD | 140.89% |
| 2015 Q2 | 34.61 Million USD | 11.0% |
| 2015 Q1 | 31.18 Million USD | 115.14% |
| 2015 Q3 | 37.14 Million USD | 7.3% |
| 2014 FY | 14.49 Million USD | 157.43% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 14.49 Million USD | 0.0% |
| 2013 FY | 5.63 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -173.587% |
| Alkermes plc | 933.53 Million USD | 1.596% |
| Agenus Inc. | 462.29 Million USD | -98.713% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 77.32% |
| Aptorum Group Limited | 5.25 Million USD | -17375.495% |
| Ardelyx, Inc. | 130.76 Million USD | -602.524% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -92.028% |
| Bicycle Therapeutics plc | 224.41 Million USD | -309.355% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -605.507% |
| ChromaDex Corporation | 26.5 Million USD | -3365.524% |
| Chimerix, Inc. | 19.74 Million USD | -4552.525% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2511.473% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -1165.921% |
| CRISPR Therapeutics AG | 346.76 Million USD | -164.915% |
| Precision BioSciences, Inc. | 140.92 Million USD | -551.888% |
| Dyadic International, Inc. | 2.34 Million USD | -39147.244% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -5548.656% |
| Fortress Biotech, Inc. | 165.93 Million USD | -453.602% |
| Lantern Pharma Inc. | 2.73 Million USD | -33430.935% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -1185.172% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -25933.227% |
| Incyte Corporation | 1.59 Billion USD | 42.306% |
| IO Biotech, Inc. | 17.55 Million USD | -5132.633% |
| Jaguar Health, Inc. | 45.86 Million USD | -1902.88% |
| Novavax, Inc. | 2.57 Billion USD | 64.287% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2447.676% |
| Opthea Limited | 264.6 Million USD | -247.179% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -602.825% |
| ContextLogic Inc. | 206 Million USD | -345.942% |
| MiMedx Group, Inc. | 96.33 Million USD | -853.64% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1812.959% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -25932.032% |
| NextCure, Inc. | 14.99 Million USD | -6025.498% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -22627.387% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -13658.29% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1865.47% |
| Vaxcyte, Inc. | 167.44 Million USD | -448.609% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2662.071% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -290.555% |
| Pharming Group N.V. | 244.07 Million USD | -276.38% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -7605.427% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -618.862% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -13803.469% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -13803.469% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -1014.409% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -13728.707% |
| Acelyrin, Inc. | 86.35 Million USD | -963.821% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -70605.974% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -6288.768% |
| Summit Therapeutics Inc. | 125.25 Million USD | -633.405% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -9591.328% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1647.429% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1235.681% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -506.316% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -46865.286% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -68683.001% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -304.987% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -9707.206% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -303.896% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -85.768% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -8317.088% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -3239.177% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -7489.127% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -88.787% |
| Immix Biopharma, Inc. | 3.72 Million USD | -24582.82% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -2329.496% |
| MEI Pharma, Inc. | 8.35 Million USD | -10895.105% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -3066.09% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -164.296% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -529.771% |
| Fortress Biotech, Inc. | 165.93 Million USD | -453.602% |
| Precigen, Inc. | 41.64 Million USD | -2105.938% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1739.858% |
| AlloVir, Inc. | 45.01 Million USD | -1940.744% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -604.82% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -566.648% |
| ImmuCell Corporation | 18.81 Million USD | -4782.486% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -3154.592% |
| Onconetix, Inc. | 23.18 Million USD | -3862.924% |
| PureTech Health plc | 125.58 Million USD | -631.501% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -10164.145% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2579.66% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -37472.229% |
| Seer, Inc. | 39.36 Million USD | -2233.649% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1385.657% |
| Innoviva, Inc. | 568.55 Million USD | -61.576% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -3273.884% |
| ESSA Pharma Inc. | 3.49 Million USD | -26183.901% |
| GlycoMimetics, Inc. | 6.9 Million USD | -13209.637% |
| GT Biopharma, Inc. | 6.63 Million USD | -13749.555% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -247.457% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -237.38% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -993.282% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -9298.823% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -3281.21% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -28378.166% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -1145.328% |
| Aptose Biosciences Inc. | 15.8 Million USD | -5710.983% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -8221.26% |
| Soligenix, Inc. | 7.27 Million USD | -12527.534% |
| Century Therapeutics, Inc. | 175.94 Million USD | -422.13% |
| Kura Oncology, Inc. | 51.66 Million USD | -1678.175% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -657.442% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -22126.978% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -13789.645% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -263.677% |
| Autolus Therapeutics plc | 263.9 Million USD | -248.093% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -8663.986% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -933.795% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1858.765% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -160.344% |
| GRI Bio, Inc. | 2.69 Million USD | -33961.587% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -113370.605% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2854.685% |
| IGM Biosciences, Inc. | 220.17 Million USD | -317.228% |
| INmune Bio, Inc. | 18.86 Million USD | -4770.327% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -258.174% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3348.118% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -33693.37% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -27905.076% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1471.535% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -855.335% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -247.004% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -11.617% |
| Verastem, Inc. | 71.18 Million USD | -1190.498% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1768.068% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -2281.256% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1777.383% |
| Histogen Inc. | 5.69 Million USD | -16024.996% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -20846.734% |
| Surrozen, Inc. | 8.14 Million USD | -11178.588% |
| Organovo Holdings, Inc. | 2.74 Million USD | -33329.44% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -292593.192% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1533.723% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -5463.475% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1697.626% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -110997.929% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -624.909% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -8395.245% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -508.819% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -35132.813% |
| Apollomics, Inc. | 14.15 Million USD | -6390.786% |
| Amarin Corporation plc | 279.58 Million USD | -228.571% |
| Mesoblast Limited | 188.79 Million USD | -386.573% |
| Turnstone Biologics Corp. | 14.14 Million USD | -6393.08% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -408.132% |
| Synaptogenix, Inc. | 5.52 Million USD | -16513.548% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -13718.306% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -440.034% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -10635.308% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -52172.941% |
| Exelixis, Inc. | 678.44 Million USD | -35.404% |
| Better Therapeutics, Inc. | 23.84 Million USD | -3753.037% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -459.99% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -54.599% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8501.343% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -56479.943% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -2259.907% |
| Gritstone bio, Inc. | 125.91 Million USD | -629.549% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6159.478% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -17952.826% |
| Avid Bioservices, Inc. | 275.66 Million USD | -233.242% |
| Insmed Incorporated | 1.66 Billion USD | 44.719% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -11839.669% |
| MediWound Ltd. | 27.18 Million USD | -3278.972% |
| OmniAb, Inc. | 87.4 Million USD | -951.077% |
| Alector, Inc. | 487.66 Million USD | -88.374% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -127.693% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -4885.84% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -2293.978% |
| Zai Lab Limited | 240.17 Million USD | -282.485% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -45.803% |
| Aura Biosciences, Inc. | 29.22 Million USD | -3043.125% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -866.207% |
| Immunic, Inc. | 25.36 Million USD | -3521.259% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1226.826% |
| Veracyte, Inc. | 93.71 Million USD | -880.208% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -35007.214% |
| FibroGen, Inc. | 585.72 Million USD | -56.837% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5184.709% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -140563.721% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -16143.441% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 88.002% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -11105.672% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -993.334% |
| TG Therapeutics, Inc. | 169.08 Million USD | -443.301% |
| Galecto, Inc. | 5.89 Million USD | -15480.75% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -10989.341% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 64.916% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -3087.291% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -7178.67% |
| XBiotech Inc. | 8.39 Million USD | -10840.11% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -6159.478% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1627.418% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -152.995% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -3317.055% |
| Theravance Biopharma, Inc. | 169 Million USD | -443.562% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 24.429% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -83.572% |
| Vaxxinity, Inc. | 30.94 Million USD | -2868.721% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 5.537% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -15131.715% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -23.269% |
| NexImmune, Inc. | 5.08 Million USD | -17968.432% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -247249.446% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -29775.981% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 87.074% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -17723.742% |
| Scopus BioPharma Inc. | 7.45 Million USD | -12223.417% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -3393.729% |
| Ainos, Inc. | 7.39 Million USD | -12323.766% |
| Pluri Inc. | 34.11 Million USD | -2593.014% |
| Prothena Corporation plc | 135.01 Million USD | -580.389% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -277.881% |
| Celularity Inc. | 102.92 Million USD | -792.5% |
| Rallybio Corporation | 9.43 Million USD | -9635.492% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3657.991% |
| MeiraGTx Holdings plc | 319.99 Million USD | -187.083% |
| Omeros Corporation | 403.25 Million USD | -127.808% |
| Humacyte, Inc. | 114.67 Million USD | -701.068% |
| Immunocore Holdings plc | 228.15 Million USD | -302.634% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -18743.918% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -1097.082% |
| CalciMedica, Inc. | 4.02 Million USD | -22706.38% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -5163.815% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -495.967% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -970.465% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -230.693% |
| Pulmatrix, Inc. | 15.96 Million USD | -5654.814% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -5724.136% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3633.402% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -266.273% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1708.847% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 24.119% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -2790.353% |
| Nutriband Inc. | 1.07 Million USD | -85044.575% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -8539.528% |
| Vor Biopharma Inc. | 59.1 Million USD | -1454.279% |
| Roivant Sciences Ltd. | 773.95 Million USD | -18.695% |
| Evogene Ltd. | 17.99 Million USD | -5006.398% |
| ProKidney Corp. | 29.21 Million USD | -3044.308% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -1176.263% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -130206.83% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 51.367% |
| CorMedix Inc. | 11.91 Million USD | -7608.318% |
| BioLineRx Ltd. | 50.7 Million USD | -1711.844% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -514.644% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -938.705% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1768.6% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2848.87% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -5014.358% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -637.059% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -16147.63% |
| MediciNova, Inc. | 3.89 Million USD | -23506.026% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -4925.663% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -60970.068% |
| GeoVax Labs, Inc. | 3.51 Million USD | -25998.638% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -131.245% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2893.291% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 66.248% |
| Mereo BioPharma Group plc | 15.96 Million USD | -5655.175% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2844.268% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1465.403% |
| Absci Corporation | 58.3 Million USD | -1475.605% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4722.769% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2765.202% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -1144.94% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -950.079% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2620.287% |
| Allakos Inc. | 74.79 Million USD | -1128.245% |
| Imunon, Inc. | 8.53 Million USD | -10668.992% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3982.667% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -700.126% |
| BioAtla, Inc. | 48.98 Million USD | -1775.313% |
| NLS Pharmaceutics AG | 10.68 Million USD | -8501.343% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -32956.531% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -603.379% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -6362.476% |
| XOMA Corporation | 145.58 Million USD | -531.021% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2628.772% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1236.03% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2807.368% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1385.921% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1943.013% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1797.94% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -31908.397% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -11160.591% |
| Akari Therapeutics, Plc | 4.58 Million USD | -19940.161% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5080.366% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 44.307% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -227338.179% |
| UroGen Pharma Ltd. | 243.52 Million USD | -277.23% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -186.103% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -33165.316% |
| Orgenesis Inc. | 35.53 Million USD | -2485.172% |
| Entera Bio Ltd. | 1.37 Million USD | -66516.461% |
| GH Research PLC | 6.7 Million USD | -13609.014% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -13409.426% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -4779.64% |
| Xencor, Inc. | 283.55 Million USD | -223.968% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -30668.285% |
| Replimune Group, Inc. | 113.21 Million USD | -711.42% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -24350.637% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -787.319% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -227338.179% |
| Portage Biotech Inc. | 4.45 Million USD | -20543.618% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -60970.068% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -3885.427% |
| OncoCyte Corporation | 49.29 Million USD | -1763.445% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -22106.534% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -115092.405% |
| Purple Biotech Ltd. | 10 Million USD | -9081.819% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -15776.962% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1504.305% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -7315.559% |
| HilleVax, Inc. | 78.9 Million USD | -1064.178% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -18090.911% |
| Tharimmune, Inc. | 1.81 Million USD | -50512.546% |
| Genprex, Inc. | 3.25 Million USD | -28129.326% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -3287.444% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -17444.71% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -445842.233% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -256111.442% |
| OKYO Pharma Limited | 7.42 Million USD | -12279.195% |
| Savara Inc. | 37.19 Million USD | -2369.996% |
| Curis, Inc. | 57.61 Million USD | -1494.531% |
| Daré Bioscience, Inc. | 26.32 Million USD | -3388.971% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -2243.484% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -63517.798% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -4312.513% |
| BeiGene, Ltd. | 2.23 Billion USD | 58.874% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -4214.935% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -250.096% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -4218.14% |
| Erasca, Inc. | 78.61 Million USD | -1068.591% |
| bluebird bio, Inc. | 424.62 Million USD | -116.342% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -140096.596% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 51.396% |
| DBV Technologies S.A. | 42.8 Million USD | -2046.357% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -140096.596% |
| Moderna, Inc. | 4.57 Billion USD | 79.907% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -13032.823% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -55373.49% |
| Molecular Templates, Inc. | 31.17 Million USD | -2847.101% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -5281.611% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -56.204% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -637.835% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -3248.183% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2419.862% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1551.193% |
| MacroGenics, Inc. | 154.2 Million USD | -495.719% |
| RenovoRx, Inc. | 4.46 Million USD | -20469.66% |
| Adicet Bio, Inc. | 37.12 Million USD | -2374.787% |
| Prime Medicine, Inc. | 60.78 Million USD | -1411.42% |
| Aditxt, Inc. | 28.53 Million USD | -3119.737% |
| Adagene Inc. | 45.16 Million USD | -1933.771% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -508276.268% |
| Quantum-Si incorporated | 26.63 Million USD | -3349.517% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -31.692% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -30094.239% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -699.089% |
| SciSparc Ltd. | 1.59 Million USD | -57495.047% |
| Vericel Corporation | 127.7 Million USD | -619.346% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -16407.79% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -976.22% |
| Generation Bio Co. | 171.63 Million USD | -435.245% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -7853.602% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -2096.077% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -263.533% |
| Invivyd, Inc. | 51.71 Million USD | -1676.422% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -898.773% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -14021.53% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -1116.808% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -89874.633% |
| 2seventy bio, Inc. | 310.12 Million USD | -196.215% |
| ADMA Biologics, Inc. | 193.97 Million USD | -373.585% |
| Clene Inc. | 38.95 Million USD | -2258.453% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2442.398% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -257.481% |
| GeoVax Labs, Inc. | 3.51 Million USD | -25998.638% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -382.827% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -7442.418% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -363.207% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -7433.055% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -1809.42% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1638.5% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -148.379% |
| Evaxion Biotech A/S | 17.61 Million USD | -5114.372% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -470.836% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -499.69% |
| Trevena, Inc. | 48.26 Million USD | -1803.446% |
| Surrozen, Inc. | 8.14 Million USD | -11178.588% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -4153.952% |
| Cingulate Inc. | 10.36 Million USD | -8766.451% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -33305.127% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -2363.373% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -25513.715% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -6885.863% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -189.608% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3596.893% |
| Clearmind Medicine Inc. | 3.61 Million USD | -25347.063% |
| Kronos Bio, Inc. | 54.2 Million USD | -1594.878% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1852.769% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3936.256% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -4476.957% |
| Statera Biopharma, Inc. | 22.67 Million USD | -3951.079% |
| ImmunityBio, Inc. | 1.09 Billion USD | 15.751% |
| Korro Bio, Inc. | 51.75 Million USD | -1675.083% |
| Kineta, Inc. | 7.22 Million USD | -12620.036% |
| BioVie Inc. | 9.7 Million USD | -9368.447% |
| Codexis, Inc. | 49.94 Million USD | -1739.268% |
| Celularity Inc. | 102.92 Million USD | -792.5% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -854.462% |
| Celcuity Inc. | 51.45 Million USD | -1685.5% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -266023.108% |
| Cibus, Inc. | 206.11 Million USD | -345.689% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -2062.78% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -3387.76% |
| IN8bio, Inc. | 8.77 Million USD | -10372.424% |
| Kodiak Sciences Inc. | 213.59 Million USD | -330.093% |
| Annexon, Inc. | 47.11 Million USD | -1849.66% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -925.945% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -853.224% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -6610.797% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 64.714% |
| Eyenovia, Inc. | 19.78 Million USD | -4544.226% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -418.754% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -11859.914% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3711.947% |
| Arcellx, Inc. | 339.75 Million USD | -170.386% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -7620.97% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -274.131% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -9506.201% |
| Moolec Science SA | 13.94 Million USD | -6487.433% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -2028.849% |
| Geron Corporation | 146.12 Million USD | -528.659% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1717.939% |
| Royalty Pharma plc | 6.29 Billion USD | 85.413% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -2209.536% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -311932.024% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -37238.85% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -385.653% |
| Humacyte, Inc. | 114.67 Million USD | -701.068% |
| Structure Therapeutics Inc. | 29.05 Million USD | -3062.166% |
| 89bio, Inc. | 59.96 Million USD | -1432.013% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -3371.417% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -76709.448% |
| Genelux Corporation | 8.42 Million USD | -10810.226% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -13299.081% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -573.891% |
| Notable Labs, Ltd. | 4.42 Million USD | -20650.87% |
| Liquidia Corporation | 73.13 Million USD | -1156.038% |
| Mustang Bio, Inc. | 17.61 Million USD | -5113.922% |
| Immunovant, Inc. | 48.95 Million USD | -1776.501% |
| Quantum-Si incorporated | 26.63 Million USD | -3349.517% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -2293.354% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -29504.931% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -1143.743% |
| Acasti Pharma Inc. | 11.55 Million USD | -7848.784% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -3963.393% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -33693.37% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -2391.095% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -67306.273% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -14969.57% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3598.977% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -3862.392% |
| PepGen Inc. | 34.63 Million USD | -2552.655% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -7464.567% |
| United Therapeutics Corporation | 1.18 Billion USD | 22.294% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -13053.508% |
| Solid Biosciences Inc. | 38.45 Million USD | -2288.686% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -10635.308% |
| Immuneering Corporation | 12 Million USD | -7550.015% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -292593.192% |
| Silo Pharma, Inc. | 1.56 Million USD | -58439.385% |
| Belite Bio, Inc | 4.21 Million USD | -21715.27% |
| XOMA Corporation | 145.58 Million USD | -531.021% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -37735.297% |
| Bionomics Limited | 10.15 Million USD | -8942.88% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -4174.538% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3909.257% |
| uniQure N.V. | 624.01 Million USD | -47.214% |
| Cassava Sciences, Inc. | 14.19 Million USD | -6371.582% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -508276.268% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -439.793% |
| Forte Biosciences, Inc. | 3.66 Million USD | -24958.402% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -352432.974% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -13515.548% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -11859.914% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -5184.709% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -8592.667% |
| Altimmune, Inc. | 16.54 Million USD | -5453.721% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -48.718% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3909.257% |
| Compugen Ltd. | 55.77 Million USD | -1547.048% |
| Peak Bio, Inc. | 20.75 Million USD | -4326.468% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -731.628% |
| Benitec Biopharma Inc. | 4.96 Million USD | -18413.523% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -481.997% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -1122.02% |
| Zura Bio Limited | 21.29 Million USD | -4214.489% |
| PolyPid Ltd. | 17.46 Million USD | -5158.994% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -717.304% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -1122.02% |
| Instil Bio, Inc. | 99.8 Million USD | -820.473% |
| argenx SE | 444.95 Million USD | -106.459% |
| Immunome, Inc. | 28.65 Million USD | -3105.531% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -10918.844% |
| Verona Pharma plc | 58.84 Million USD | -1461.226% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -6247.274% |
| Shattuck Labs, Inc. | 14.85 Million USD | -6082.388% |
| CervoMed Inc. | 2.59 Million USD | -35290.236% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -18747.784% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -7112.948% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -8619.896% |
| Moolec Science SA | 13.94 Million USD | -6487.433% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -39099.464% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1552.372% |
| AnaptysBio, Inc. | 364.28 Million USD | -152.176% |
| Design Therapeutics, Inc. | 11.95 Million USD | -7583.515% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -7142.518% |
| NeurAxis, Inc. | 1.91 Million USD | -47927.514% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -2259.846% |
| Lumos Pharma, Inc. | 13.33 Million USD | -6789.98% |
| Achilles Therapeutics plc | 19.08 Million USD | -4712.915% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -6247.274% |
| 180 Life Sciences Corp. | 5.38 Million USD | -16952.262% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -3794.529% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3936.256% |
| Nutriband Inc. | 1.07 Million USD | -85044.575% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2902.291% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -6230.653% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -128.931% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2728.938% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -6939.882% |
| Palisade Bio, Inc. | 2.73 Million USD | -33439.284% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -17387.931% |
| Beam Therapeutics Inc. | 478.38 Million USD | -92.03% |
| Neurogene Inc. | 36.54 Million USD | -2413.45% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -130.843% |
| AEON Biopharma, Inc. | 159.88 Million USD | -474.549% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1827.893% |
| Sesen Bio, Inc. | 30.98 Million USD | -2864.888% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -3438.542% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -11983.858% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -369.322% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -378.317% |
| Athira Pharma, Inc. | 30.05 Million USD | -2956.33% |
| Vaccinex, Inc. | 5.94 Million USD | -15360.131% |
| HCW Biologics Inc. | 15.05 Million USD | -6003.139% |
| XOMA Corporation | 145.58 Million USD | -531.021% |
| Nektar Therapeutics | 267.04 Million USD | -244.001% |
| Arvinas, Inc. | 644.6 Million USD | -42.513% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -5080.366% |
| Merus N.V. | 102.15 Million USD | -799.297% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -527.701% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -865.771% |
| Rezolute, Inc. | 11.73 Million USD | -7728.882% |
| Clene Inc. | 38.95 Million USD | -2258.453% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -32162.677% |
| BeyondSpring Inc. | 48.26 Million USD | -1803.17% |
| Synlogic, Inc. | 32.89 Million USD | -2692.646% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -6186.464% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -56120.379% |
| Peak Bio, Inc. | 20.75 Million USD | -4326.468% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1347.613% |
| Krystal Biotech, Inc. | 39.71 Million USD | -2213.141% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -143.902% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -822.617% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -212191.612% |
| MannKind Corporation | 721.36 Million USD | -27.347% |
| Ikena Oncology, Inc. | 22.33 Million USD | -4013.011% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -43938.399% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -795.449% |
| Gossamer Bio, Inc. | 249.14 Million USD | -268.714% |
| CohBar, Inc. | 1.03 Million USD | -88774.538% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -8494.265% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -4722.769% |
| Legend Biotech Corporation | 589.93 Million USD | -55.72% |
| Mural Oncology plc | 37.92 Million USD | -2322.065% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -592.603% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -39922.141% |
| Disc Medicine, Inc. | 22.87 Million USD | -3915.917% |
| Champions Oncology, Inc. | 28.03 Million USD | -3176.765% |
| REGENXBIO Inc. | 262.22 Million USD | -250.321% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -27245.78% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -7229.193% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -6739.387% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -4232.191% |
| Vaxart, Inc. | 34.02 Million USD | -2599.9% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -4405.513% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -3119.7% |
| Cellectis S.A. | 249.57 Million USD | -268.082% |
| Longeveron Inc. | 5.33 Million USD | -17112.685% |
| Repare Therapeutics Inc. | 41.81 Million USD | -2096.707% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 61.807% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1421.735% |
| Revolution Medicines, Inc. | 262.39 Million USD | -250.096% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -43499.478% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -10549.675% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -7684.434% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -6441.629% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -42607.624% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 82.162% |
| Denali Therapeutics Inc. | 122.96 Million USD | -647.087% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -16407.79% |
| Veru Inc. | 32.81 Million USD | -2699.65% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -13273.723% |
| Cingulate Inc. | 10.36 Million USD | -8766.451% |
| Passage Bio, Inc. | 39.26 Million USD | -2239.771% |
| Context Therapeutics Inc. | 4.19 Million USD | -21815.636% |
| Exicure, Inc. | 8.54 Million USD | -10645.596% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -3013.193% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -8660.643% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -4067.874% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -463.632% |
| Nuvalent, Inc. | 31.82 Million USD | -2786.72% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -14340.347% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1357.651% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -5003.561% |
| OmniAb, Inc. | 87.4 Million USD | -951.077% |
| Anew Medical, Inc. | 8.24 Million USD | -11046.122% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -2299.224% |
| Lipocine Inc. | 2.63 Million USD | -34807.694% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -3396.654% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -2184.495% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -3348.118% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -966.278% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -16908.721% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -1010.18% |
| Ocugen, Inc. | 23.98 Million USD | -3730.384% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1879.531% |
| Q32 Bio Inc. | 233.12 Million USD | -294.05% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -10032.815% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1617.022% |
| Equillium, Inc. | 27.95 Million USD | -3185.907% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -344.664% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -16226.563% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -14878.735% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -483.909% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -1223.061% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -9110.171% |
| Dominari Holdings Inc. | 4.63 Million USD | -19719.655% |
| Edesa Biotech, Inc. | 1.84 Million USD | -49781.763% |
| vTv Therapeutics Inc. | 29.56 Million USD | -3006.981% |
| Bio-Techne Corporation | 744.34 Million USD | -23.417% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -628.508% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -166.693% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -2164.057% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -3072.432% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -894.631% |
| Nkarta, Inc. | 105.6 Million USD | -769.925% |
| BioCardia, Inc. | 4.59 Million USD | -19913.965% |
| Iterum Therapeutics plc | 32.66 Million USD | -2712.568% |